RECENT NEWS
Blood test could reduce antibiotic use in sepsis patients
A simple daily blood test could help critically ill sepsis patients come off antibiotics sooner, potentially reducing drug overuse and helping tackle the growing threat of antibiotic resistance, new research shows.
A quicker route to market for innovative diagnostics
Abingdon Health, an international developer, manufacturer and regulatory services provider for rapid diagnostic tests and medical technology, announces it has signed a Memorandum of Understanding with Centre for Process Innovation (CPI) to explore opportunities for collaboration across the medtech sector.
New blood test to help guide prostate cancer treatment decisions
A blood test could help identify men with advanced prostate cancer who are more likely to experience longer disease control following targeted radiotherapy, according to new research.
UK AMR infections continue to rise
National surveillance data published by the UK Health Security Agency (UKHSA) show the total number of antibiotic-resistant infections continued to rise in 2025, with an average of 406 reported cases each week.
MHRA to tackle evidence gaps on women’s health
Women are set to benefit from better evidence on medicines and medical devices, including how their risks and benefits may differ for women, under a new programme launched today by the Medicines and Healthcare products Regulatory Agency (MHRA).
Cepheid’s Xpert Respiratory Panel gains CE marking under IVDR
Cepheid has announced that it has achieved CE marking under the In Vitro Medical Device Regulation (IVDR) for the Xpert Respiratory Panel, a multiplex PCR test designed to detect 13 common viral and bacterial respiratory pathogens from a single nasopharyngeal swab sample.
Royal colleges call for reform of MDT working in NHS cancer care
The Royal College of Pathologists (RCPath) has collaborated with the Royal College of Radiologists and other medical royal colleges and associations to call for reform of cancer multidisciplinary team meetings, claiming resource-intensive formal MDT meetings are often inefficient and describing the current model as ‘broken’.
Launch Diagnostics rebrands as Palex
Launch Diagnostics will officially become Palex Diagnostics UK Ltd from 1 January 2027. This change reflects the company’s integration into the wider Palex Group, a European healthcare and diagnostics firm, which acquired Launch during 2025.
Making tumours more responsive to immunotherapy
In a new international study led by Lund University in Sweden, researchers have uncovered how reprogrammed cancer cells can help orchestrate the immune system’s attack on tumours.
Two new candidate vaccines to join Ebola trial
Expert groups convened by the World Health Organization (WHO) have recommended adding two new Ebola vaccine candidates to the ongoing Tumaini clinical trial in the Democratic Republic of the Congo (DRC).
BioUK announces SEHTA acquisition
BioUK, the not-for-profit membership organisation focused on catalysing success in UK life sciences, has announced that it has acquired certain key assets of SEHTA (Science and Engineering Health Technologies Alliance) through an asset purchase agreement.
Bio-Rad expands precision oncology research portfolio
Bio-Rad Laboratories has expanded its precision oncology research portfolio with new tools designed to support mutation detection research, liquid biopsy workflows, tumour-informed assay development, molecular residual disease (MRD) research, and multiplex biomarker analysis.
Measuring virus-specific antibodies deep in the lungs without bronchoscopy
A new scientific study by researchers at Karolinska Institutet, Danderyd Hospital and Uppsala University demonstrates that samples collected using a non-invasive method called PExA can be used to measure virus-specific antibodies from the small airways.
Discovery of new genetic variants give insight into breast cancer risk
Scientists have carried out one of the largest experimental studies of breast cancer variants to date, helping pinpoint genetic changes that are most likely to contribute to the development of the disease.
Agilent introduces NovoStation system for automated flow cytometry
Agilent Technologies has announced the launch of the NovoStation Sample Preparation System, a new automated platform designed to help laboratories simplify and streamline flow cytometry sample preparation.
NHS launches new cancer blood test trial
A world-leading new trial is being launched across at least 200 GP practices in England aimed at providing earlier diagnosis for a range of the most common cancers.
New strategy identified for treating lupus
Researchers at the University of California, Riverside (UCR) have identified a new strategy for treating systemic lupus erythematosus (SLE), an autoimmune disease in which the immune system attacks healthy tissues.
No eligibility changes for spring 2027 COVID-19 vaccinations
The UK Government has confirmed eligibility for the spring 2027 COVID-19 vaccination programme in line with advice from the Joint Committee on Vaccination and Immunisation (JCVI).
UKHSA launches human biomonitoring study
The UK Health Security Agency (UKHSA) is conducting a human biomonitoring study as part of a programme of work to improve understanding of levels of per- and polyfluoroalkyl substances (PFAS) and other chemicals such as lead, arsenic and flame retardants, in the UK population and the potential implications for health.
RCPath supports Which? concerns on high-street vitamin D kits
The Royal College of Pathologists (RCPath) has joined calls from Which? for consumers to carefully consider the accuracy and suitability of rapid vitamin D self-test kits that are sold on the high street.
Latest Issues
Beckman Coulter Diagnostics is a global leader in advanced diagnostics, helping laboratories transform insight into impact through science, technology, and collaboration. For more than 90 years, the company has challenged convention to elevate the role of the diagnostic laboratory, accelerating ideas from discovery to real world clinical outcomes....
DIA-MHRA Global Summit
Senate House, Malet Street, London, WC1E 7HU
16-17 November, 2026
UK NEQAS for Microbiology & Parasitology Annual Scientific Meeting 2026
The Royal National Hotel, 38 – 51 Bedford Way, London, WC1H 0DG
27 November, 2026
UK NEQAS webinar: Epigenetics
Online
1 December, 2026
Weqas Annual POCT Conference 2026
London, Venue - TBC
8-9 December, 2026
UK NEQAS webinar: Fresh Muscle Biopsies
Online
8 December, 2026